Related Experiment Video
Updated: Aug 11, 2026
Fast and Specific Assessment of the Halogenating Peroxidase Activity in Leukocyte-enriched Blood Samples
Published on: July 28, 2016
The use of myeloperoxidase as a risk marker for atherosclerosis
1Section of Cardiology, Baylor College of Medicine, 6550 Fannin, SM 677, Houston, TX 77030, USA. vnambi@bcm.tmc.edu
Abstract:
The mechanisms of atheroma formation and their ensuing complications and methods by which these can be detected have been the focus of several in vitro, in vivo, and clinical studies. Myeloperoxidase (MPO) is a microbicidal hemoprotein that serves as a part of the neutrophils' armory in host defense. However, the oxidation products generated by MPO have now been shown to be related to various stages of atheroma development. MPO and its oxidant products have been shown to be capable of modifying low-density lipoprotein cholesterol and to be enriched in human atheromas and rupture-prone plaques. Clinical studies have suggested an association between levels of MPO and the presence of coronary artery disease and endothelial dysfunction, and have shown a possible additional role to troponin in patients with chest pain.
Insights
Myeloperoxidase (MPO) is linked to atheroma development and complications. Elevated MPO levels may indicate coronary artery disease and endothelial dysfunction, potentially aiding in chest pain diagnosis.
Area of Science:
- Biochemistry
- Cardiovascular Biology
- Immunology
Background:
- Atheroma formation and complications are extensively studied.
- Myeloperoxidase (MPO) is a neutrophil-derived hemoprotein crucial for host defense.
- MPO's role extends beyond immunity, influencing cardiovascular pathology.
Purpose of the Study:
- To investigate the role of Myeloperoxidase (MPO) in atheroma development.
- To explore MPO's contribution to cardiovascular disease pathogenesis and detection.
Main Methods:
- In vitro, in vivo, and clinical studies were conducted.
- Analysis of MPO's effects on low-density lipoprotein cholesterol.
- Assessment of MPO levels in human atheromas and patient cohorts.
Main Results:
- MPO and its oxidation products are implicated in atheroma progression.
- MPO modifies low-density lipoprotein cholesterol, promoting atherogenesis.
- MPO is enriched in human atheromas, particularly rupture-prone plaques.
- Clinical studies associate MPO levels with coronary artery disease and endothelial dysfunction.
Conclusions:
- Myeloperoxidase (MPO) plays a significant role in the development and progression of atherosclerosis.
- MPO may serve as a biomarker for cardiovascular disease and a diagnostic aid in chest pain evaluation.
- Further research into MPO's mechanisms can inform therapeutic strategies for atheroma-related conditions.
More Related Videos
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
07:57Imaging and Analysis of Oil Red O-Stained Whole Aorta Lesions in an Aneurysm Hyperlipidemia Mouse Model
Published on: May 2, 2022